InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Discover the complete record of transactions filed by Thackray Helen M., Directeur R&D. Director active across 1 companies, notably Biocryst Pharmaceuticals INC. In total, 3 reports have been logged. Total volume traded: €111k. The latest transaction was disclosed on 1 April 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
€111,1967,600 shares@ €14.6310.0067% mcap100.0% of flow
Common Stock
SEC:0001127602-22-011188:0·
044,000 shares0
Common Stock
SEC:0001127602-21-031130·
044,000 shares0
Common Stock
SEC:0001127602-21-031130:0·
3 of 3 declarations
About Thackray Helen M.
Helen M. Thackray is the Chief R&D Officer at BIOCRYST PHARMACEUTICALS INC. In this role, she oversees the company's research and development initiatives, focusing on innovation and product improvement. Helen brings scientific and technical expertise, enabling her to lead complex research projects. Her commitment to innovation is essential for the success of BIOCRYST.
